【ChiCTR1900021592】Real-time Ultrasound Guided Spinal Anaesthesia: Comparison of the Transverse Interspinous In-plane and Paramedian Saggital Oblique In-plane Injection Techniques
ChiCTR1900021592
尚未开始
/
/
/
2019-02-28
/
/
Musculoskeletal system and connective tissue
Real-time Ultrasound Guided Spinal Anaesthesia: Comparison of the Transverse Interspinous In-plane and Paramedian Saggital Oblique In-plane Injection Techniques
Real-time Ultrasound Guided Spinal Anaesthesia: Comparison of the Transverse Interspinous In-plane and Paramedian Saggital Oblique In-plane Injection Techniques
The objective of this prospective, randomized study is to compare the cerebrospinal fluid (CSF) efflux time using either the traditional paramedian spinal anaesthesia using the Paramedian sagittal oblique (PMSO) window from the non-dependent side, or the transverse in-plane dependent (TIPD) technique from the dependent side, with the patient in the lateral decubitus position.
随机平行对照
Ⅳ期
After recruitment, subjects (both male and female) will be randomly allocated to receive real-time USG SI using either the TIPD or PMSO technique. The randomization sequence will be generated using an online randomization software (www.randomization.com) and prepared by a third party (Research assistant).
double blinding
香港中文大學威爾斯親王醫院麻醉與重症監護部
/
20
/
2019-04-08
2020-05-30
/
Adult patients, American Society of Anesthesiologists (ASA) physical status I-III, age between 20 to 85 years, and patients scheduled to undergo elective groin, lower limb, lower abdominal gynaecological and urogenital surgery under spinal anesthesia.；
请登录查看Patient refusal or unwilling to participate in the study, ASA physical status > Ⅲ, spinal deformity, previous spine surgery, pregnancy, coagulopathy, allergy to local anesthetic drugs, skin infection at the site of needle insertion, severe Cardiac disease like atrial stenosis, atrial fibrillation, ongoing ischemic heart disease, autonomic dysfunction, and sepsis；
请登录查看香港中文大學威爾斯親王醫院麻醉與重症監護部
/
香港中文大學威爾斯親王醫院麻醉與重症監護部的其他临床试验
威爾斯親王醫院麻醉與重症監護部的其他临床试验
最新临床资讯
-
Nat Rev Clin Oncol｜AI赋能肿瘤临床试验：从流程优化到证据生成的全景透视
智药邦2026-08-12
-
康臣药业1类新药糖肾方“芪箭颗粒”获NMPA临床研究许可
康臣药业2026-08-12
-
璎黎药业2026-08-12
-
幂方健康基金2026-08-12
-
细胞与基因治疗领域2026-08-12
-
云南白药2026-08-12
-
细胞治疗前沿2026-08-12
-
广州达博生物制品有限公司2026-08-12
-
医药笔记2026-08-12
-
医药笔记2026-08-12
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29